Risk, disorder and diagnosis

References

• Gottesman II. Schizophrenia genesis: the origin of madness. New York: Freeman, 1991.
   Google Scholar
• Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P. Signs of asphixia at birth and risk of schizophrenia: population-based case-control study. Br J Psychiatry 2001; 179:403–408.
   PubMed Web of Science ®Google Scholar
• Kunugi H, Nanko S, Murray RM. Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br J Psychiatry 2001; 178S40: 25–29.
   Google Scholar
• Jones P, Rodgers B, Murray R, Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994; 344:1398–1402.
   PubMed Web of Science ®Google Scholar
• Cannon M, Caspi A, Moffitt TE . Evidence for early-childhood pan-developmental impairment specific to schizophreniform disorder: tesults from a longitudinal birth cohort. Arch Gen Psychiatry 2002; 59:449–457.
   PubMed Web of Science ®Google Scholar
• Read J, van Os J, Morrison A, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005; 112:330–350.
   PubMed Web of Science ®Google Scholar
• Yung A, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996; 22:353–370.
   PubMed Web of Science ®Google Scholar
• Yung AR, Phillips LJ, Yuen HP . Psychosis prediction: 12-month follow up of a high-risk (‘prodromal’) group. Schizophr Res 2003; 60:21–32.
   PubMed Web of Science ®Google Scholar
• Moller P, Husby R. The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. Schizophr Bull 2000; 26:217–232.
   PubMed Web of Science ®Google Scholar
• Scott J, Chant D, Andrews G, McGrath J. Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychol Med 2006; 36: 231–238.
   PubMed Web of Science ®Google Scholar
• Tien AY. Distributions of hallucinations in the population. Soc Psychiatry Psychiatr Epidemiol 1991; 26:287–292.
   PubMed Web of Science ®Google Scholar
• Van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban–rural comparison. Arch Gen Psychiatry 2001; 58: 663–668.
   PubMed Web of Science ®Google Scholar
• Van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A sytematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder. Psychol Med 2009; 39:179–195.
   PubMed Web of Science ®Google Scholar
• Yung AR, Nelson B, Baker K, Buckby J, Baksheev G, Cosgrave E. Psychotic-like experiences in a community sample of adolescents: implications for the continuum model of psychosis and prediction of schizophrenia. Aust N Z J Psychiatry 2009; 43:118–128.
   PubMed Web of Science ®Google Scholar
• McGorry PD. Pre-emptive intervention in psychosis: agnostic rather than diagnostic. Aust N Z J Psychiatry 2011; 45:515–519.
   PubMed Web of Science ®Google Scholar
• Yung AR, Phillips LJ, McGorry PD. Treating schizophrenia in the prodromal phase. London: Taylor and Francis; 2004.
   Google Scholar
• Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004; 67:131–42.
   PubMed Web of Science ®Google Scholar
• Cannon TD, Cadenhead K, Cornblatt B . Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008; 65:28–37.
   PubMed Web of Science ®Google Scholar
• Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 2006; 113:247–272.
   PubMed Web of Science ®Google Scholar
• Yung AR, Yuen HP, Berger G . Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 2007; 33:673–681.
   PubMed Web of Science ®Google Scholar
• Ruhrmann S, Schultze-Lutter F, Salokangas RKR . Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European Prediction of Psychosis Study. Arch Gen Psychiatry 2010; 67:241–251.
   PubMed Web of Science ®Google Scholar
• Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P. Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull 2010. doi:10.1093/schbul/sbq088
   PubMed Web of Science ®Google Scholar
• Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res 2010; 116: 168–172.
   PubMed Web of Science ®Google Scholar
• Lemos-Giráldez S, Vallina-Fernández O, Fernández-Iglesias P . Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res 2009; 115: 121–129.
   PubMed Web of Science ®Google Scholar
• Riecher-Rossler A, Pflueger MO, Aston J . Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry 2009; 66:1023–1030.
   PubMed Web of Science ®Google Scholar
• Broome MR, Woolley JB, Johns LC . Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. Eur Psychiatry 2005; 20:372–378.
   PubMed Web of Science ®Google Scholar
• Haroun N, Dunn L, Haroun A, Cadenhead K. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006; 32:166–178.
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Addington J, Cannon T . Recruitment and treatment practices for help-seeking ‘prodromal’ patients. Schizophr Bull 2007; 33:715–726.
   PubMed Web of Science ®Google Scholar
• Rosenman S, Anderson P. Does prodromal diagnosis delay early intervention? Aust N Z J Psychiatry 2011; 45:509–514.
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins D . Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790–799.
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ . Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59:921–928.
   PubMed Web of Science ®Google Scholar
• Yung AR, Phillips LJ, Nelson B . Randomized controlled trial of interventions for young people at ultra high risk of psychosis: 6 month analysis. J Clin Psychiatry 2011; 72:430–440.
   PubMed Web of Science ®Google Scholar
• Morrison AP, French P, Walford L . Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004; 185:291–297.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Schäfer M, Papageorgiou K . Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67:146–154.
   PubMed Web of Science ®Google Scholar
• Drake R, Lewis S. Valuing prodromal psychosis: what do we get and what is the price? Schizophr Res 2010; 120:38–41.
   PubMed Web of Science ®Google Scholar
• Yung AR, Nelson B, Thompson AD, Wood SJ. Should a ‘risk syndrome for psychosis’ be included in the DSM-V? Schizophr Res 2010; 120:7–15.
   PubMed Web of Science ®Google Scholar
• Nelson B, Yung AR. Should a risk syndrome for first episode psychosis be included in DSM-V? Curr Op Psychiatry 2011; 24:128–133.
   PubMed Web of Science ®Google Scholar
• Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including attenuated psychotic symptoms syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res 2010; 123:199–207.
   PubMed Web of Science ®Google Scholar
• McGorry PD. Risk syndromes, clinical staging and DSM-V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res 2010; 120:49–53.
   PubMed Web of Science ®Google Scholar
• Corcoran C, First MB, Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk–benefit analysis. Schizophr Res 2010; 120:16–22.
   PubMed Web of Science ®Google Scholar
• Ruhrmann S, Schulze-Lutter F, Klosterkoetter J. Probably at-risk, but certainly ill – advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res 2010; 120:23–37.
   PubMed Web of Science ®Google Scholar
• Yang LH, Wonpat-Borja AJ, Opler MG, Corcoran CM. Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question. Schizophr Res 2010; 120:42–48.
   PubMed Web of Science ®Google Scholar
• Carpenter WT. Anticipating DSM-V: Should psychosis risk become a diagnostic class? Schizophr Bull 2009; 35:841–843.
   PubMed Web of Science ®Google Scholar
• David AS. Should the diagnostic boundaries of schizophrenia be expanded? Cogn Neuropsychiatry 2011; 16:97–100.
   PubMed Web of Science ®Google Scholar
• Johannessen JO, McGorry P. DSM-5 and the ‘psychosis risk syndrome’: the need for a broader perspective. Psychosis: Psychol Soc Integr Approach 2010; 2:93–96.
   Google Scholar
• Ross CA. DSM-5 and the ‘psychosis risk syndrome’: eight reasons to reject it. Psychosis: Psychol Soc Integr Approach 2010; 2:107–110.
   Google Scholar
• Carpenter WT. Should attenuated psychosis syndrome be a DSM-5 diagnosis? Amer J Psychiatry 2011; 168:460–463.
   PubMed Web of Science ®Google Scholar
• Cooper R. What is wrong with the DSM? Hist Psychiatry 2004; 15:5–25.
   Web of Science ®Google Scholar
• Kazdin AE. Mediators and mechanisms of change in psychotherapy research. Ann Rev Clin Psychol 2007; 3:1–27.
   PubMed Web of Science ®Google Scholar
• Shendler J. The efficacy of psychodynamic psychotherapy. Am Psychol 2010; 65:98–109.
   PubMed Web of Science ®Google Scholar
• Tucker GJ. Putting DSM IV in perspective. Am J Psychiatry 1998; 155:159–161.
   PubMed Web of Science ®Google Scholar
• Anand S, Malhi GS. From manual to Bible: the questionable hegemony of DSM IV. Aust N Z J Psychiatry 2011; 45: 348–350.
   PubMed Web of Science ®Google Scholar
• Andreasen NC. DSM and the death of phenomenology in America: an example of unintended consequences. Schizophr Bull 2007; 33:108–112.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Munoz RA, Murphy G. The development of the Feighner criteria: a historical perspective. Am J Psychiatry 2010; 167:134–142.
   PubMed Web of Science ®Google Scholar
• Svirskis T, Korkeila J, Heinimaa M . Axis-I disorders and vulnerability to psychosis. Schizophr Res 2005, 439–446.
   PubMed Web of Science ®Google Scholar
• Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 2004; 68: 37–48.
   PubMed Web of Science ®Google Scholar
• International Early Psychosis Association, Addington J, Amminger GP . International clinical practice guidelines for early psychosis. Br J Psychiatry 2005; 187S48:120–124.
   Google Scholar
• McGorry P. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005; 39:1–30.
   PubMed Web of Science ®Google Scholar
• Reich W. The spectrum concept of schizophrenia: problems for diagnostic practice. Arch Gen Psychiatry 1975; 32:489–498.
   PubMed Web of Science ®Google Scholar
• Corcoran C, Malaspina D, Hercher L. Prodromal interventions for schizophrenia vulnerability: the risks of being ‘at risk’. Schizophr Res 2005; 73:173–184.
   PubMed Web of Science ®Google Scholar